Metsera, which is developing weight-loss drugs, said on Monday it is seeking a valuation of up to $1.78 billion in its U.S.

Wednesday, November 30, 2022. Graham has battled excess weight for years, cycling through trendy diets, various drugs, and even bariatric surgery. she started a new medication, Mounjaro ...

A new weight loss drug could see patients lose double the amount ... Wegovy and Mounjaro in the last three months of 2022, with companies racing to expand supply to meet the demand.

Novo Nordisk said a higher dose of its drug Wegovy led to greater weight loss in patients during a late-stage trial, but the ...

An analyst thinks he has cracked the code on why highflying Eli Lilly missed two quarters of Wall Street projections.

The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, ...

But a new class of weight-loss drugs that help people shed pounds without ... MariTide, or AMG 133, first unveiled in late 2022, is now in Phase II trials. Amgen (AMGN) said its plans for a ...

it has been barred by an old federal law from paying for weight-loss drugs. But last November Biden proposed new rules to allow Medicare and Medicaid to pay for these meds. The change would not ...

Diabetes and weight loss drugs Ozempic and Wegovy have been added to the list of medications selected for Medicare price ...

Compounded by the equally sudden banning of the weight loss drug, phen-fen (phentermine-fenfluramine ... there remained no new promising pharmaceutical agents addressing obesity.